BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Narciso-Schiavon JL, Schiavon LL. Autoantibodies in chronic hepatitis C: A clinical perspective. World J Hepatol 2015; 7(8): 1074-1085 [PMID: 26052396 DOI: 10.4254/wjh.v7.i8.1074]
URL: https://www.wjgnet.com/1007-9327/full/v7/i8/1074.htm
Number Citing Articles
1
Marta Priora, Richard Borrelli, Simone Parisi, Maria Chiara Ditto, Cristina Realmuto, Angela Laganà, Chiara Centanaro Di Vittorio, Rosanna Degiovanni, Clara Lisa Peroni, Enrico Fusaro. Autoantibodies and Rheumatologic Manifestations in Hepatitis C Virus InfectionBiology 2021; 10(11): 1071 doi: 10.3390/biology10111071
2
Oleg Kurtenkov, Jelena Jakovleva, Boris Sergejev, Julia Geller. Association of the Sialylation of Antibodies Specific to the HCV E2 Envelope Glycoprotein with Hepatic Fibrosis Progression and Antiviral Therapy EfficacyDisease Markers 2020; 2020: 1 doi: 10.1155/2020/8881279
3
Bilal Olcay Peker, Aslı Gamze Şener, Firdevs Topal, Elif Sarıtaş Yüksel. The relevance between anti‐rods/rings antibody and different treatment regimens in chronic hepatitis C virus infectionMicrobiology and Immunology 2021; 65(4): 171 doi: 10.1111/1348-0421.12879
4
Francesca Marciano, Marcella Savoia, Pietro Vajro. Celiac disease-related hepatic injury: Insights into associated conditions and underlying pathomechanismsDigestive and Liver Disease 2016; 48(2): 112 doi: 10.1016/j.dld.2015.11.013
5
Amandeep Singh, Nayere Zaeri, Immanuel K. Ho. Onset of Celiac Disease after Treatment of Chronic Hepatitis C with Interferon Based Triple TherapyCase Reports in Hepatology 2015; 2015: 1 doi: 10.1155/2015/763497
6
Simon H. Bridge, Sabrina Pagano, Meleri Jones, Graham R. Foster, Dermot Neely, Nicolas Vuilleumier, Margaret F. Bassendine. Autoantibody to apolipoprotein A-1 in hepatitis C virus infection: a role in atherosclerosis?Hepatology International 2018; 12(1): 17 doi: 10.1007/s12072-018-9842-5
7
Gregor Schweighofer Zwink, Christian Pirich. The Role of Pendrin in Health and Disease2017; : 85 doi: 10.1007/978-3-319-43287-8_6
8
Camila C. Simoes, Omar A. Saldarriaga, Netanya S. Utay, Ashley E. Stueck, Sheharyar K. Merwat, Shehzad N. Merwat, Thomas D. Schiano, Maria Isabel Fiel, Heather L. Stevenson. Direct‐Acting Antiviral Treatment of Patients with Hepatitis C Resolves Serologic and Histopathologic Features of Autoimmune HepatitisHepatology Communications 2019; 3(8): 1113 doi: 10.1002/hep4.1388
9
Geison Luiz Costa de Castro, Carlos David A. Bichara, Angélica Menezes Santiago, William Botelho de Brito, Leonn Mendes Soares Pereira, Tuane Carolina Ferreira Moura, Ednelza da Silva Graça Amoras, Mauro Sérgio Moura de Araújo, Simone Regina Souza da Silva Conde, Maria Alice Freitas Queiroz, Ricardo Ishak, Antonio Carlos Rosário Vallinoto. Polymorphisms in the TGFB1 and FOXP3 genes are associated with the presence of antinuclear antibodies in chronic hepatitis CHeliyon 2020; 6(7): e04524 doi: 10.1016/j.heliyon.2020.e04524
10
Mohamed Emara, Esraa Mohsen, Riham M. Shawky, Ramadan A. El-Domany. Assessment of the Prevalence of Non-Organ-Specific Autoantibodies in Egyptian Patients with HCVImmunological Investigations 2020; 49(6): 676 doi: 10.1080/08820139.2019.1699108
11
S. John Calise, Nicola Bizzaro, Thuy Nguyen, Danila Bassetti, Brunetta Porcelli, Paolo Almi, Giuseppina Barberio, Giampaola Pesce, Minoru Satoh, Edward K. L. Chan. Anti-rods/rings autoantibody seropositivity does not affect response to telaprevir treatment for chronic hepatitis C infectionAutoimmunity Highlights 2016; 7(1) doi: 10.1007/s13317-016-0087-9
12
O V Moskalets. Role of infections in autoimmune disease developmentKazan medical journal 2017; 98(4): 586 doi: 10.17750/KMJ2017-586
13
Pooja Deshpande, Christine Bundell, Elizabeth McKinnon, Margaret Hellard, Rosemary Ffrench, Anna L. Wilkinson, Heidi Drummer, Silvana Gaudieri, Michaela Lucas. Frequent occurrence of low-level positive autoantibodies in chronic hepatitis CPathology 2020; 52(5): 576 doi: 10.1016/j.pathol.2020.05.001
14
Gianfranco LAULETTA, Sebastiano CICCO, Franco DAMMACCO. Hepatitis C virus-related autoimmunity before and after viral clearance: a single center, prospective, observational studyMinerva Medica 2024; 115(3) doi: 10.23736/S0026-4806.24.09170-5
15
Aref Shariati, Hamid R. Aslani, Mohammad R.H. Shayesteh, Ali Taghipour, Ahmad Nasser, Hossein Safari, Mahmood Alizade-Sani, Amin Dehghan, Taher Azimi. Are Viruses and Parasites Linked to Celiac Disease? A Question that Still has no Definite AnswerCurrent Pharmaceutical Biotechnology 2019; 20(14): 1181 doi: 10.2174/1389201020666190828124924
16
Luz Marina Navarta, Carlos Alberto Espul, Nelson Acosta‐Rivero. High prevalence of a variety of autoantibodies in a population of hepatitis C virus‐infected individualsAPMIS 2018; 126(6): 515 doi: 10.1111/apm.12850
17
Wolfgang Poller, Ziya Kaya, Marion Muche, Mario Kasner, Carsten Skurk, Kai Kappert, Rudolf Tauber, Felicitas Escher, Heinz-Peter Schultheiss, Hans-Jörg Epple, Ulf Landmesser. High incidence of cardiac dysfunction and response to antiviral treatment in patients with chronic hepatitis C virus infectionClinical Research in Cardiology 2017; 106(7): 551 doi: 10.1007/s00392-017-1086-1
18
Wolfgang Poller, Arash Haghikia, Mario Kasner, Ziya Kaya, Udo Bavendiek, Heiner Wedemeier, Hans-Jörg Epple, Carsten Skurk, Ulf Landmesser. Cardiovascular Involvement in Chronic Hepatitis C Virus Infections – Insight from Novel Antiviral TherapiesJournal of Clinical and Translational Hepatology 2018; 6(2): 1 doi: 10.14218/JCTH.2017.00057
19
Endrit Shahini, Andrea Iannone, Domenico Romagno, Angelo Armandi, Sonia Carparelli, Mariabeatrice Principi, Maria Teresa Viggiani, Enzo Ierardi, Alfredo Di Leo, Michele Barone. Clinical relevance of serum non‐organ‐specific antibodies in patients with HCV infection receiving direct‐acting antiviral therapyAlimentary Pharmacology & Therapeutics 2018; 48(10): 1138 doi: 10.1111/apt.14999
20
Geison Luiz Costa de Castro, Ednelza da Silva Graça Amoras, Mauro Sérgio Araújo, Simone Regina Souza da Silva Conde, Carlos David Araújo Bichara, Maria Alice Freitas Queiroz, Antonio Carlos Rosário Vallinoto. High prevalence of antinuclear antibodies in patients with chronic hepatitis C virus infectionEuropean Journal of Medical Research 2022; 27(1) doi: 10.1186/s40001-022-00809-6
21
Laura López Couceiro, Elena Gómez Domínguez, Raquel Muñoz Gómez, Gregorio Castellano Tortajada, Carolina Ibarrola de Andrés, Inmaculada Fernández Vázquez. Healing of autoimmune hepatitis associated with hepatitis C virus infection treated with direct-acting antiviralsRevista Española de Enfermedades Digestivas 2018; 110 doi: 10.17235/reed.2018.5528/2018
22
Ciro Romano, Olga Tortorella, Liliana Dalla Mora, Dario Di Stasio, Ausilia Sellitto, Luigi Elio Adinolfi, Aldo Marrone. Prevalence and Outcome of Serum Autoantibodies in Chronic Hepatitis C Patients Undergoing Direct-Acting Antiviral TreatmentFrontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.882064
23
Alicia Lowenstein, Hugo Fainboim, Adriana Reyes, Cynthia Lutzky, Beatriz Ameigeiras, Teresa Schroder, Maria Laura Eugenio Russmann. Autoimmune and non-autoimmune thyroid dysfunction in HCV infected and HCV–HIV co-infected patients before and after interferon alpha therapy: A prospective studyEndocrinología, Diabetes y Nutrición 2020; 67(4): 263 doi: 10.1016/j.endinu.2019.04.012
24
Catherine Johanet, Yannick Chantran, Eric Ballot. Auto-anticorps et pathologies hépatiquesRevue Francophone des Laboratoires 2017; 2017(490): 45 doi: 10.1016/S1773-035X(17)30078-3
25
Daniele Serranti, Giuseppe Indolfi, Gabriella Nebbia, Mara Cananzi, Lorenzo D’Antiga, Silvia Ricci, Stefano Stagi, Chiara Azzari, Massimo Resti. Transient Hypothyroidism and Autoimmune Thyroiditis in Children With Chronic Hepatitis C Treated With Pegylated-interferon-α-2b and RibavirinPediatric Infectious Disease Journal 2018; 37(4): 287 doi: 10.1097/INF.0000000000001791
26
Alicia Lowenstein, Hugo Fainboim, Adriana Reyes, Cynthia Lutzky, Beatriz Ameigeiras, Teresa Schroder, Maria Laura Eugenio Russmann. Autoimmune and non-autoimmune thyroid dysfunction in HCV infected and HCV–HIV co-infected patients before and after interferon alpha therapy: A prospective studyEndocrinología, Diabetes y Nutrición (English ed.) 2020; 67(4): 263 doi: 10.1016/j.endien.2020.06.005
27
Janaína Luz Narciso-Schiavon, Leonardo Lucca Schiavon. To screen or not to screen? Celiac antibodies in liver diseasesWorld Journal of Gastroenterology 2017; 23(5): 776-791 doi: 10.3748/wjg.v23.i5.776